Current Opinion in Immunology
Current Opinion in Immunology
5 years ago

Vaccines against mucosal infections

There remains a great need to develop vaccines against many of the pathogens that infect mucosal tissues or have a mucosal port of entry. Parenteral vaccination may protect in some instances, but usually a mucosal vaccination route is necessary. Mucosal vaccines also have logistic advantages over injectable vaccines by being easier to administer, having less risk of transmitting infections and potentially being easier to manufacture. Still, however, only relatively few vaccines for human use are available: oral vaccines against cholera, typhoid, polio, and rotavirus, and a nasal vaccine against influenza. For polio, typhoid and influenza, in which the pathogens reach the blood stream, there is also an injectable vaccine alternative. A problem with available oral live vaccines is their reduced immunogenicity when used in developing countries; for instance, the efficacy of rotavirus vaccines correlates closely with the national per capita income. Research is needed to define the impact of factors such as malnutrition, aberrant intestinal microflora, concomitant infections, and preexisting immunity as well as of host genetic factors on the immunogenicity of these vaccines.

Highlights

► Effective immunization against mucosal infections usually requires topical-mucosal vaccine administration. ► The mucosal immune system exhibits anatomic compartmentalization related to the migratory patterns of lymphocytes activated at different mucosal sites. ► Sublingual immunization is a promising new approach that results in strong systemic and broadly disseminated mucosal antibody and T cell responses. ► The immunogenicity of oral live vaccines is reduced when used in underprivileged populations in developing countries. ► This “tropical barrier” to oral live vaccines may be due to chronic environmental enteropathy, nutritional problems, aberrant intestinal microflora, concomitant helminth and other infections, and preexisting active or passive (serum and breast-milk antibody) immunity.

Publisher URL: www.sciencedirect.com/science

DOI: S0952791512000635

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.